NeuRizer Balance Sheet Health
Financial Health criteria checks 4/6
NeuRizer has a total shareholder equity of A$73.0M and total debt of A$1.9M, which brings its debt-to-equity ratio to 2.6%. Its total assets and total liabilities are A$129.3M and A$56.3M respectively.
Key information
2.6%
Debt to equity ratio
AU$1.89m
Debt
| Interest coverage ratio | n/a |
| Cash | AU$568.72k |
| Equity | AU$73.02m |
| Total liabilities | AU$56.30m |
| Total assets | AU$129.32m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: NRZ's short term assets (A$570.7K) do not cover its short term liabilities (A$54.5M).
Long Term Liabilities: NRZ's short term assets (A$570.7K) do not cover its long term liabilities (A$1.8M).
Debt to Equity History and Analysis
Debt Level: NRZ's net debt to equity ratio (1.8%) is considered satisfactory.
Reducing Debt: NRZ's debt to equity ratio has reduced from 13.4% to 2.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NRZ has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: NRZ is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.